Pharmaceuticals, Biotechnology and Life Sciences
WESTLAKE VILLAGE, Calif., July 23, 2025 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing…
Idorsia will publish its Half Year 2025 Financial Reporting on Wednesday July 30, at 07:00 CEST. An investor webcast and…
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) — With consumers increasingly turning to natural wellness products, THCa flower has become…
BERWYN, Pa., July 23, 2025 (GLOBE NEWSWIRE) — AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical…
New Iso-Seq data from ~1,000 samples to expand transcriptomic insights using highly accurate HiFi sequencingMENLO PARK, Calif., July 23, 2025…
VANCOUVER, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage biopharmaceutical company developing Site Specific Immunomodulators (SSIs),…
BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”)…
Vancouver, Canada, July 23, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a…
ZUG, Switzerland, July 22, 2025 (GLOBE NEWSWIRE) — Pharvaris N.V. (“Pharvaris,” Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral…
Not For Distribution to United States News Wire Services or for Dissemination in the United States CALGARY, Alberta, July 22,…